Category Archives: Oncolytic Virus Therapy Research

26Jun/18

PD1 VS CTLA-4: Which Works Better in the Combination Therapy with Oncolytic Virus?

June 26, 2018Oncolytic Virus Therapy ResearchOncolytic virus immunotherapy, T cell immunotherapies, T-Vecbiocart

Cancers don’t come from anything but result from unexpected mutations in human cells with the uncontrolled proliferation of cells as the most important feature. The cells in the body undergo mutations atRead More…

27Feb/18

Oncolytic Virus Significantly Prolong Patients’ Survival in Brain Tumor Treatment

February 27, 2018Oncolytic Virus Therapy ResearchCAR-T, oncolytic adenovirus, Oncolytic Virusbiocart

The latest achievement published in Journal of Clinical Oncology showed that a common cold virus could attack deadly brain tumors to prolong patient survival after genetic modification. Researchers from the MD AndersonRead More…

22Nov/17

Chinese Scientists Discovered Strong Oncolytic Virus Synergist

November 22, 2017Oncolytic Virus Therapy ResearchOncolytic Virusbiocart

On August 24th, a reporter was informed from Prof. Guangmei Yan research group at Zhongshan University that this group of researchers identified and gained oncolytic virus M1 synergist with accurate treatment of biomarkers. TheyRead More…